ConductScience.org, home

Paper42908038PubMed

Pregnancy outcome after first-trimester exposure to JAK inhibitors - an evaluation of the German Embryotox cohort.

Habbel AS and 3 others. BMC Pharmacol Toxicol, 2026.

Cite this record

ConductScience Library. Pregnancy outcome after first-trimester exposure to JAK inhibitors - an evaluation of the German Embryotox cohort. Papers, record 42908038. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42908038

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Pregnancy outcome after first-trimester exposure to JAK inhibitors - an evaluation of the German Embryotox cohort.
Journal
BMC Pharmacol Toxicol
Year
2026
Publication types
Journal Article, Observational Study
Revised in PubMed
2026-10-26

Source PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Habbel ASAnna-Sophia
2Beck EEvelin
3Mueller AAnne
4Dathe KKatarina

Source PubMed

Download CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Pregnancy OutcomeMajor topic
Janus Kinase InhibitorsMajor topic
Abnormalities, Drug-InducedMajor topic
Humans
Female
Pregnancy
Germany
Pregnancy Trimester, First
Adult
Cohort Studies

Source PubMed

Download CSV of topics

References42

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
140370416Upadacitinib as Rescue Therapy in a Pregnant Patient With IBD.ACG Case Rep J2025https://conductscience.org/library/papers/40370416PubMed
239008024Pregnancy Outcomes in Patients Treated with Upadacitinib: Analysis of Data from Clinical Trials and Postmarketing Reports.Drug Saf2024https://conductscience.org/library/papers/39008024PubMed
339626694Prevalence, Incidence, and Age at Diagnosis of Boys With Hypospadias: A Nationwide Population-Based Epidemiological Study.J Urol2025https://conductscience.org/library/papers/39626694PubMed
438591862Tofacitinib as a Rescue Therapy for Ulcerative Colitis in Pregnancy.Inflamm Bowel Dis2024https://conductscience.org/library/papers/38591862PubMed
531972425The role of JAK/STAT signaling pathway and its inhibitors in diseases.Int Immunopharmacol2020https://conductscience.org/library/papers/31972425PubMed
638317692Normal Infant Immunologic Assessment and Uneventful Live Rotavirus Vaccination Despite Continuous Tofacitinib Exposure In Utero and During Breastfeeding.Crohns Colitis 3602024https://conductscience.org/library/papers/38317692PubMed
733915094Miscarriage matters: the epidemiological, physical, psychological, and economic costs of early pregnancy loss.Lancet2021https://conductscience.org/library/papers/33915094PubMed
837208335Evolving cognition of the JAK-STAT signaling pathway: autoimmune disorders and cancer.Signal Transduct Target Ther2023https://conductscience.org/library/papers/37208335PubMed
938202041Reproductive Safety Issues of Novel Small Molecules for the Treatment of Inflammatory Bowel Disease: A Systematic Review.J Clin Med2023https://conductscience.org/library/papers/38202041PubMed
1041305879Janus Kinase Inhibitors During Pregnancy and Adverse Drug Reactions: A Pharmacovigilance Disproportionality Analysis in VigiBase.Clin Transl Sci2025https://conductscience.org/library/papers/41305879PubMed
1137795665Pregnancy outcome of a patient treated with upadacitinib for severe atopic dermatitis.J Eur Acad Dermatol Venereol2024https://conductscience.org/library/papers/37795665PubMed
1234874264Pregnancy and Autoimmune Disease.Dtsch Arztebl Int2022https://conductscience.org/library/papers/34874264PubMed
1329063150Drug safety in pregnancy: the German Embryotox institute.Eur J Clin Pharmacol2018https://conductscience.org/library/papers/29063150PubMed
1438309493Tofacitinib in Pregnancy: Assessing Pregnancy and Infant Outcomes, Cord Blood, and Breast Milk Concentrations.Clin Gastroenterol Hepatol2025https://conductscience.org/library/papers/38309493PubMed
1541486192Pharmacological targeting of the JAK-STAT pathway: new concepts and emerging indications.Nat Rev Drug Discov2026https://conductscience.org/library/papers/41486192PubMed
1625644395Does the average drug exposure in pregnant women affect pregnancy outcome? A comparison of two approaches to estimate the baseline risks of adverse pregnancy outcome.Pharmacoepidemiol Drug Saf2015https://conductscience.org/library/papers/25644395PubMed
1738970379Use of Upadacitinib as Salvage Therapy for Ulcerative Colitis in Pregnancy: A Case Report.Inflamm Bowel Dis2025https://conductscience.org/library/papers/38970379PubMed
1841002213Pregnancy Outcomes After Maternal or Paternal Exposure to Tofacitinib Across Clinical Programs.Am J Gastroenterol2026https://conductscience.org/library/papers/41002213PubMed
1934824210The JAK/STAT signaling pathway: from bench to clinic.Signal Transduct Target Ther2021https://conductscience.org/library/papers/34824210PubMed
2034309233Fetal exposure to tofacitinib during the first trimester: A healthy newborn case report.Birth Defects Res2021https://conductscience.org/library/papers/34309233PubMed

See all 42 referencesDownload CSV of references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/42908038

GET https://conductscience.org/api/papers/v1/42908038/references?page=2